Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Visus Therapeutics Appoints Ophthalmology Industry Expert Jehan Tamboowalla to Senior Vice President of Business Development and Marketing
Visus Therapeutics, a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapeutics for the front […]
Standigm Announces Younsung Choo as Chief Executive Officer (CEO)
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that Younsung […]
Collective Health Announces Appointment of Dr. Linda Grais to Board of Directors
Collective Health has announced the addition of Dr Linda Grais, a seasoned physician and biopharma […]
Legend Biotech Announces Appointment of Chief Medical Officer
Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on developing a novel treatment for acute ischemic […]
HuidaGene Appoints New Members to the Scientific Advisory Board
HuidaGene Therapeutics (辉大基因; HuidaGene), a global clinical-stage biotechnology company focused on developing genomic medicine, has […]
Ochre Bio Strengthens Leadership Team and Board of Directors with Liver Disease Translational Expertise
Ochre Bio, an innovator in chronic liver disease medicine development, is pleased to announce the […]
Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Abivax, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune […]
SamaCare Welcomes Komodo Health CEO Arif Nathoo to Board of Directors
SamaCare, a prior authorization platform for physician-administered medications, is excited to announce the addition of […]
Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more